Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2005265148 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Weber, Ann E.; Feng, Danqing Dennis; Singh, Suresh; Biftu, Tesfaye; Gao, Ying-Duo

Agent Spruson & Ferguson

Pub. Number AU-B-2005265148

PCT Pub. Number WO2006/009886

Priority 60/581,536 21.06.04 US

Filing date 17 June 2005

Wipo publication date 26 January 2006

Acceptance publication date 20 January 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/404 (2006.01)

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61K 31/4743 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/009886 Priority application(s): WO2006/009886

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

20 January 2011 Application Accepted

  Published as AU-B-2005265148

19 May 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265150-C-MET kinase binding proteins

2005265147-Specifically compatible connectors for administration of stored gases